This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.


 
Bill:  HB 3236 
Legislative Session: 85(R) Council Document: 85R 12947 JG-D
Add to Bill List
Last Action:05/16/2017 S Referred to State Affairs
Caption Version:Engrossed
Caption Text:Relating to the costs associated with the provision of certain investigational drugs, biological products, and devices that are in clinical trials.
Author:Kacal | King, Ken | Rodriguez, Eddie | Ashby
Subjects:Health Care Providers (I0387)
Health--General (I0385)
Health--Other Diseases & Medical Conditions (I0383)
MEDICINE & PRESCRIPTION DRUGS (S7338)
House Committee:Public Health
Status:Out of committee
Vote:Ayes=10   Nays=0   Present Not Voting=0   Absent=1
Senate Committee:State Affairs
Status:In committee
Actions: (descending date order)
Viewing Votes: Most Recent House Vote
Description Comment Date       Time       Journal Page
 Referred to State Affairs      05/16/2017     2001
 Read first time      05/16/2017     2001
 Received from the House      05/15/2017     1920
 Reported engrossed      05/12/2017   04:36 PM  3492
 Record vote   RV#1243   05/12/2017     3430
 Passed      05/12/2017     3430
 Read 3rd time      05/12/2017     3430
 Statement(s) of vote recorded in Journal      05/11/2017     3379
 Record vote   RV#1203   05/11/2017     3378
 Passed to engrossment      05/11/2017     3378
 Amendment withdrawn   1-Schaefer   05/11/2017     3378
 Statement(s) of vote recorded in Journal      05/11/2017     3378
 Record vote   RV#1202   05/11/2017     3378
 Motion prevails      05/11/2017     3378
 Motion for the previous question      05/11/2017     3377
 Amendment(s) offered   1-Schaefer   05/11/2017     3377
 Read 2nd time      05/11/2017     3377
 Placed on General State Calendar      05/08/2017    
 Considered in Calendars      05/05/2017    
 Committee report sent to Calendars      05/04/2017    
 Committee report distributed      05/04/2017   08:17 AM 
 Comte report filed with Committee Coordinator      05/03/2017     2646
 Reported favorably w/o amendment(s)      04/27/2017    
 Considered in formal meeting      04/27/2017    
 Left pending in committee      04/18/2017    
 Testimony taken/registration(s) recorded in committee      04/18/2017    
 Considered in public hearing      04/18/2017    
 Scheduled for public hearing on . . .      04/18/2017    
 Referred to Public Health      03/30/2017   01:18 PM  980
 Read first time      03/30/2017     980
 Filed      03/07/2017